360 High-Risk Vulnerability Immunization Tool V2.0 vs AppLocker Guidance: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

AppLocker Guidance: A repository containing scripts and configuration files to help administrators implement Microsoft AppLocker for application whitelisting based on NSA security guidelines..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). AppLocker Guidance is open-source with 232 GitHub stars. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and AppLocker Guidance serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Windows Security. Key differences: 360 High-Risk Vulnerability Immunization Tool V2.0 is Commercial while AppLocker Guidance is Free, AppLocker Guidance is open-source. Review the feature comparison above to determine which fits your requirements.